Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Letter to the Editor

Open Access Gateway

Potential Role of Brain-Derived Neurotrophic Factor in Omega–3 Fatty Acid Supplementation to Prevent Posttraumatic Distress after Accidental Injury: An Open-Label Pilot Study

Matsuoka Y.a, b, c · Nishi D.a, b, c · Yonemoto N.b, c · Hamazaki K.c, d · Hamazaki T.c, e · Hashimoto K.c, f

Author affiliations

aDepartment of Psychiatry, National Disaster Medical Center, bNational Center of Neurology and Psychiatry, and cCREST, Japan Science and Technology Agency, Tokyo, dDepartment of Public Health, Faculty of Medicine, and eDepartment of Clinical Sciences, Institute of Natural Medicine, University of Toyama, Toyama, and fDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan

Corresponding Author

Yutaka Matsuoka

Department of Adult Mental Health

National Institute of Mental Health

National Center of Neurology and Psychiatry

4-1-1 Ogawahigashi-cho, Kodaira

Tokyo 187-8553 (Japan)

Tel. +81 42 346 1975, Fax +81 42 346 1986

E-Mail yutaka@ncnp.go.jp

Related Articles for ""

Psychother Psychosom 2011;80:310–312

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.




First-Page Preview
Abstract of Letter to the Editor

Article / Publication Details

Received: March 04, 2010
Accepted: November 11, 2010
Published online: June 30, 2011
Issue release date: July 2011

Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: http://www.karger.com/PPS


Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.